nodes	percent_of_prediction	percent_of_DWPC	metapath
Erythromycin—ABCC1—Vandetanib—thyroid cancer	0.217	0.249	CbGbCtD
Erythromycin—ABCC1—Epirubicin—thyroid cancer	0.149	0.171	CbGbCtD
Erythromycin—ABCC1—Doxorubicin—thyroid cancer	0.0794	0.0911	CbGbCtD
Erythromycin—CYP3A7—Sorafenib—thyroid cancer	0.0646	0.0742	CbGbCtD
Erythromycin—CYP3A7-CYP3A51P—Sorafenib—thyroid cancer	0.0646	0.0742	CbGbCtD
Erythromycin—CYP2B6—Sorafenib—thyroid cancer	0.0616	0.0707	CbGbCtD
Erythromycin—CYP3A5—Sorafenib—thyroid cancer	0.0485	0.0557	CbGbCtD
Erythromycin—CYP2B6—Doxorubicin—thyroid cancer	0.0374	0.0429	CbGbCtD
Erythromycin—CYP1A2—Sorafenib—thyroid cancer	0.0361	0.0414	CbGbCtD
Erythromycin—ABCB1—Sorafenib—thyroid cancer	0.0316	0.0362	CbGbCtD
Erythromycin—CYP3A4—Vandetanib—thyroid cancer	0.0314	0.036	CbGbCtD
Erythromycin—ABCB1—Doxorubicin—thyroid cancer	0.0191	0.022	CbGbCtD
Erythromycin—CYP3A4—Sorafenib—thyroid cancer	0.0189	0.0217	CbGbCtD
Erythromycin—CYP3A4—Doxorubicin—thyroid cancer	0.0115	0.0132	CbGbCtD
Erythromycin—Electrocardiogram QT prolonged—Vandetanib—thyroid cancer	0.00501	0.0502	CcSEcCtD
Erythromycin—Torsade de pointes—Vandetanib—thyroid cancer	0.00459	0.0459	CcSEcCtD
Erythromycin—Ventricular arrhythmia—Vandetanib—thyroid cancer	0.00434	0.0435	CcSEcCtD
Erythromycin—Tubulointerstitial nephritis—Vandetanib—thyroid cancer	0.0042	0.0421	CcSEcCtD
Erythromycin—Tubulointerstitial nephritis—Sorafenib—thyroid cancer	0.00283	0.0284	CcSEcCtD
Erythromycin—Sensitisation—Epirubicin—thyroid cancer	0.00224	0.0225	CcSEcCtD
Erythromycin—Sensitisation—Doxorubicin—thyroid cancer	0.00208	0.0208	CcSEcCtD
Erythromycin—Skin exfoliation—Sorafenib—thyroid cancer	0.00207	0.0207	CcSEcCtD
Erythromycin—Pancreatitis—Vandetanib—thyroid cancer	0.00198	0.0198	CcSEcCtD
Erythromycin—Hepatic function abnormal—Sorafenib—thyroid cancer	0.0018	0.018	CcSEcCtD
Erythromycin—Stevens-Johnson syndrome—Vandetanib—thyroid cancer	0.00178	0.0179	CcSEcCtD
Erythromycin—Erythema multiforme—Vandetanib—thyroid cancer	0.00153	0.0153	CcSEcCtD
Erythromycin—Arrhythmia—Vandetanib—thyroid cancer	0.00144	0.0144	CcSEcCtD
Erythromycin—Toxic epidermal necrolysis—Sorafenib—thyroid cancer	0.00142	0.0142	CcSEcCtD
Erythromycin—Dysgeusia—Vandetanib—thyroid cancer	0.00138	0.0138	CcSEcCtD
Erythromycin—Pancreatitis—Sorafenib—thyroid cancer	0.00133	0.0134	CcSEcCtD
Erythromycin—Abdominal discomfort—Sorafenib—thyroid cancer	0.0013	0.0131	CcSEcCtD
Erythromycin—Eruption—Epirubicin—thyroid cancer	0.0013	0.0131	CcSEcCtD
Erythromycin—Convulsion—Vandetanib—thyroid cancer	0.00122	0.0122	CcSEcCtD
Erythromycin—Eruption—Doxorubicin—thyroid cancer	0.00121	0.0121	CcSEcCtD
Erythromycin—Stevens-Johnson syndrome—Sorafenib—thyroid cancer	0.0012	0.012	CcSEcCtD
Erythromycin—Chest pain—Vandetanib—thyroid cancer	0.0012	0.012	CcSEcCtD
Erythromycin—Redness—Epirubicin—thyroid cancer	0.00119	0.0119	CcSEcCtD
Erythromycin—Jaundice—Sorafenib—thyroid cancer	0.00118	0.0118	CcSEcCtD
Erythromycin—Burning sensation—Epirubicin—thyroid cancer	0.00115	0.0116	CcSEcCtD
Erythromycin—Redness—Doxorubicin—thyroid cancer	0.0011	0.011	CcSEcCtD
Erythromycin—Ventricular arrhythmia—Epirubicin—thyroid cancer	0.00108	0.0108	CcSEcCtD
Erythromycin—Burning sensation—Doxorubicin—thyroid cancer	0.00107	0.0107	CcSEcCtD
Erythromycin—Erythema multiforme—Sorafenib—thyroid cancer	0.00103	0.0103	CcSEcCtD
Erythromycin—Tinnitus—Sorafenib—thyroid cancer	0.00102	0.0102	CcSEcCtD
Erythromycin—Ventricular arrhythmia—Doxorubicin—thyroid cancer	0.001	0.01	CcSEcCtD
Erythromycin—Decreased appetite—Vandetanib—thyroid cancer	0.000997	0.00999	CcSEcCtD
Erythromycin—Pain—Vandetanib—thyroid cancer	0.000981	0.00983	CcSEcCtD
Erythromycin—Arrhythmia—Sorafenib—thyroid cancer	0.000973	0.00975	CcSEcCtD
Erythromycin—Erythema—Sorafenib—thyroid cancer	0.000948	0.0095	CcSEcCtD
Erythromycin—Gastrointestinal pain—Vandetanib—thyroid cancer	0.000938	0.0094	CcSEcCtD
Erythromycin—Dysgeusia—Sorafenib—thyroid cancer	0.000929	0.0093	CcSEcCtD
Erythromycin—Abdominal pain—Vandetanib—thyroid cancer	0.000907	0.00908	CcSEcCtD
Erythromycin—Pruritus—Vandetanib—thyroid cancer	0.000812	0.00813	CcSEcCtD
Erythromycin—Ventricular tachycardia—Epirubicin—thyroid cancer	0.000802	0.00803	CcSEcCtD
Erythromycin—Diarrhoea—Vandetanib—thyroid cancer	0.000785	0.00786	CcSEcCtD
Erythromycin—Anaphylactic shock—Sorafenib—thyroid cancer	0.000774	0.00775	CcSEcCtD
Erythromycin—Skin exfoliation—Epirubicin—thyroid cancer	0.000765	0.00767	CcSEcCtD
Erythromycin—Dizziness—Vandetanib—thyroid cancer	0.000759	0.0076	CcSEcCtD
Erythromycin—Ventricular tachycardia—Doxorubicin—thyroid cancer	0.000742	0.00743	CcSEcCtD
Erythromycin—Anorexia—Sorafenib—thyroid cancer	0.000738	0.00739	CcSEcCtD
Erythromycin—Vomiting—Vandetanib—thyroid cancer	0.000729	0.00731	CcSEcCtD
Erythromycin—Rash—Vandetanib—thyroid cancer	0.000723	0.00725	CcSEcCtD
Erythromycin—Skin exfoliation—Doxorubicin—thyroid cancer	0.000708	0.00709	CcSEcCtD
Erythromycin—Nausea—Vandetanib—thyroid cancer	0.000681	0.00683	CcSEcCtD
Erythromycin—Decreased appetite—Sorafenib—thyroid cancer	0.000673	0.00674	CcSEcCtD
Erythromycin—Hepatic function abnormal—Epirubicin—thyroid cancer	0.000666	0.00667	CcSEcCtD
Erythromycin—Pain—Sorafenib—thyroid cancer	0.000662	0.00663	CcSEcCtD
Erythromycin—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000633	0.00634	CcSEcCtD
Erythromycin—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.000616	0.00617	CcSEcCtD
Erythromycin—Urticaria—Sorafenib—thyroid cancer	0.000615	0.00616	CcSEcCtD
Erythromycin—Abdominal pain—Sorafenib—thyroid cancer	0.000612	0.00613	CcSEcCtD
Erythromycin—Hypersensitivity—Sorafenib—thyroid cancer	0.00057	0.00571	CcSEcCtD
Erythromycin—Pruritus—Sorafenib—thyroid cancer	0.000548	0.00548	CcSEcCtD
Erythromycin—Liver function test abnormal—Epirubicin—thyroid cancer	0.000537	0.00538	CcSEcCtD
Erythromycin—Diarrhoea—Sorafenib—thyroid cancer	0.000529	0.0053	CcSEcCtD
Erythromycin—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.000524	0.00525	CcSEcCtD
Erythromycin—Dizziness—Sorafenib—thyroid cancer	0.000512	0.00513	CcSEcCtD
Erythromycin—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000497	0.00498	CcSEcCtD
Erythromycin—Pancreatitis—Epirubicin—thyroid cancer	0.000493	0.00494	CcSEcCtD
Erythromycin—Vomiting—Sorafenib—thyroid cancer	0.000492	0.00493	CcSEcCtD
Erythromycin—Rash—Sorafenib—thyroid cancer	0.000488	0.00489	CcSEcCtD
Erythromycin—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000485	0.00486	CcSEcCtD
Erythromycin—Nausea—Sorafenib—thyroid cancer	0.00046	0.0046	CcSEcCtD
Erythromycin—Pancreatitis—Doxorubicin—thyroid cancer	0.000456	0.00457	CcSEcCtD
Erythromycin—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000445	0.00445	CcSEcCtD
Erythromycin—Jaundice—Epirubicin—thyroid cancer	0.000437	0.00438	CcSEcCtD
Erythromycin—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000411	0.00412	CcSEcCtD
Erythromycin—Jaundice—Doxorubicin—thyroid cancer	0.000404	0.00405	CcSEcCtD
Erythromycin—Hepatitis—Epirubicin—thyroid cancer	0.000403	0.00403	CcSEcCtD
Erythromycin—Erythema multiforme—Epirubicin—thyroid cancer	0.000381	0.00381	CcSEcCtD
Erythromycin—Tinnitus—Epirubicin—thyroid cancer	0.000375	0.00376	CcSEcCtD
Erythromycin—MLNR—GPCR ligand binding—SST—thyroid cancer	0.000375	0.0128	CbGpPWpGaD
Erythromycin—Hepatitis—Doxorubicin—thyroid cancer	0.000372	0.00373	CcSEcCtD
Erythromycin—CYP3A7—Metapathway biotransformation—CHST14—thyroid cancer	0.000366	0.0125	CbGpPWpGaD
Erythromycin—MLNR—GPCR ligand binding—CALCA—thyroid cancer	0.000361	0.0123	CbGpPWpGaD
Erythromycin—Arrhythmia—Epirubicin—thyroid cancer	0.00036	0.0036	CcSEcCtD
Erythromycin—ABCC1—S1P1 pathway—PTGS2—thyroid cancer	0.000358	0.0123	CbGpPWpGaD
Erythromycin—CYP3A4—Liver X Receptor Pathway—RXRA—thyroid cancer	0.000353	0.0121	CbGpPWpGaD
Erythromycin—Erythema multiforme—Doxorubicin—thyroid cancer	0.000352	0.00353	CcSEcCtD
Erythromycin—Erythema—Epirubicin—thyroid cancer	0.00035	0.00351	CcSEcCtD
Erythromycin—CYP1A2—Arachidonic acid metabolism—HPGD—thyroid cancer	0.00035	0.012	CbGpPWpGaD
Erythromycin—Tinnitus—Doxorubicin—thyroid cancer	0.000347	0.00348	CcSEcCtD
Erythromycin—Dysgeusia—Epirubicin—thyroid cancer	0.000343	0.00344	CcSEcCtD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—RET—thyroid cancer	0.000342	0.0117	CbGpPWpGaD
Erythromycin—Arrhythmia—Doxorubicin—thyroid cancer	0.000333	0.00333	CcSEcCtD
Erythromycin—Erythema—Doxorubicin—thyroid cancer	0.000324	0.00325	CcSEcCtD
Erythromycin—Dysgeusia—Doxorubicin—thyroid cancer	0.000318	0.00318	CcSEcCtD
Erythromycin—MLNR—Signaling Pathways—CALCB—thyroid cancer	0.000315	0.0108	CbGpPWpGaD
Erythromycin—Vertigo—Epirubicin—thyroid cancer	0.000315	0.00315	CcSEcCtD
Erythromycin—Palpitations—Epirubicin—thyroid cancer	0.00031	0.0031	CcSEcCtD
Erythromycin—CYP2B6—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000307	0.0105	CbGpPWpGaD
Erythromycin—Convulsion—Epirubicin—thyroid cancer	0.000304	0.00304	CcSEcCtD
Erythromycin—CYP3A5—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.0003	0.0103	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—TRIM33—thyroid cancer	0.000299	0.0102	CbGpPWpGaD
Erythromycin—Chest pain—Epirubicin—thyroid cancer	0.000298	0.00299	CcSEcCtD
Erythromycin—Discomfort—Epirubicin—thyroid cancer	0.000295	0.00295	CcSEcCtD
Erythromycin—Vertigo—Doxorubicin—thyroid cancer	0.000291	0.00292	CcSEcCtD
Erythromycin—Confusional state—Epirubicin—thyroid cancer	0.000288	0.00289	CcSEcCtD
Erythromycin—Palpitations—Doxorubicin—thyroid cancer	0.000287	0.00287	CcSEcCtD
Erythromycin—Anaphylactic shock—Epirubicin—thyroid cancer	0.000286	0.00286	CcSEcCtD
Erythromycin—Convulsion—Doxorubicin—thyroid cancer	0.000281	0.00281	CcSEcCtD
Erythromycin—Chest pain—Doxorubicin—thyroid cancer	0.000276	0.00277	CcSEcCtD
Erythromycin—Discomfort—Doxorubicin—thyroid cancer	0.000273	0.00273	CcSEcCtD
Erythromycin—Anorexia—Epirubicin—thyroid cancer	0.000273	0.00273	CcSEcCtD
Erythromycin—MLNR—GPCR downstream signaling—TSHR—thyroid cancer	0.000272	0.00931	CbGpPWpGaD
Erythromycin—CYP2B6—Metapathway biotransformation—CHST14—thyroid cancer	0.00027	0.00925	CbGpPWpGaD
Erythromycin—Confusional state—Doxorubicin—thyroid cancer	0.000267	0.00267	CcSEcCtD
Erythromycin—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000265	0.00265	CcSEcCtD
Erythromycin—CYP3A5—Metapathway biotransformation—CHST14—thyroid cancer	0.000264	0.00904	CbGpPWpGaD
Erythromycin—Anorexia—Doxorubicin—thyroid cancer	0.000252	0.00253	CcSEcCtD
Erythromycin—CYP3A7—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000251	0.00858	CbGpPWpGaD
Erythromycin—Decreased appetite—Epirubicin—thyroid cancer	0.000249	0.00249	CcSEcCtD
Erythromycin—MLNR—Signaling by GPCR—TSHR—thyroid cancer	0.000247	0.00846	CbGpPWpGaD
Erythromycin—Pain—Epirubicin—thyroid cancer	0.000245	0.00245	CcSEcCtD
Erythromycin—MLNR—Signaling by GPCR—PRKAR1A—thyroid cancer	0.000243	0.00832	CbGpPWpGaD
Erythromycin—Feeling abnormal—Epirubicin—thyroid cancer	0.000236	0.00236	CcSEcCtD
Erythromycin—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000234	0.00234	CcSEcCtD
Erythromycin—Decreased appetite—Doxorubicin—thyroid cancer	0.00023	0.0023	CcSEcCtD
Erythromycin—Urticaria—Epirubicin—thyroid cancer	0.000227	0.00228	CcSEcCtD
Erythromycin—Pain—Doxorubicin—thyroid cancer	0.000226	0.00227	CcSEcCtD
Erythromycin—Abdominal pain—Epirubicin—thyroid cancer	0.000226	0.00226	CcSEcCtD
Erythromycin—ABCB1—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000226	0.00774	CbGpPWpGaD
Erythromycin—Feeling abnormal—Doxorubicin—thyroid cancer	0.000218	0.00218	CcSEcCtD
Erythromycin—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000216	0.00217	CcSEcCtD
Erythromycin—MLNR—GPCR downstream signaling—SST—thyroid cancer	0.000212	0.00724	CbGpPWpGaD
Erythromycin—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	0.000211	0.00723	CbGpPWpGaD
Erythromycin—Hypersensitivity—Epirubicin—thyroid cancer	0.000211	0.00211	CcSEcCtD
Erythromycin—SLC22A7—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.000211	0.0072	CbGpPWpGaD
Erythromycin—SLC22A7—SLC-mediated transmembrane transport—CP—thyroid cancer	0.000211	0.0072	CbGpPWpGaD
Erythromycin—Urticaria—Doxorubicin—thyroid cancer	0.00021	0.00211	CcSEcCtD
Erythromycin—MLNR—Signaling by GPCR—PTCH1—thyroid cancer	0.00021	0.00719	CbGpPWpGaD
Erythromycin—Abdominal pain—Doxorubicin—thyroid cancer	0.000209	0.0021	CcSEcCtD
Erythromycin—MLNR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—thyroid cancer	0.000208	0.0071	CbGpPWpGaD
Erythromycin—SLC22A7—Fluoropyrimidine Activity—TP53—thyroid cancer	0.000204	0.00698	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—CALCA—thyroid cancer	0.000204	0.00697	CbGpPWpGaD
Erythromycin—CYP3A7—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000203	0.00695	CbGpPWpGaD
Erythromycin—Pruritus—Epirubicin—thyroid cancer	0.000202	0.00203	CcSEcCtD
Erythromycin—ABCB1—HIF-1-alpha transcription factor network—CP—thyroid cancer	0.000201	0.00689	CbGpPWpGaD
Erythromycin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—thyroid cancer	0.000201	0.00686	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—TCF7L1—thyroid cancer	0.000199	0.00683	CbGpPWpGaD
Erythromycin—Diarrhoea—Epirubicin—thyroid cancer	0.000196	0.00196	CcSEcCtD
Erythromycin—Hypersensitivity—Doxorubicin—thyroid cancer	0.000195	0.00195	CcSEcCtD
Erythromycin—MLNR—Signaling by GPCR—SST—thyroid cancer	0.000192	0.00658	CbGpPWpGaD
Erythromycin—Dizziness—Epirubicin—thyroid cancer	0.000189	0.00189	CcSEcCtD
Erythromycin—Pruritus—Doxorubicin—thyroid cancer	0.000187	0.00188	CcSEcCtD
Erythromycin—CYP2B6—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000185	0.00634	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—CALCA—thyroid cancer	0.000185	0.00633	CbGpPWpGaD
Erythromycin—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000184	0.00631	CbGpPWpGaD
Erythromycin—Vomiting—Epirubicin—thyroid cancer	0.000182	0.00182	CcSEcCtD
Erythromycin—CYP3A5—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000181	0.0062	CbGpPWpGaD
Erythromycin—Diarrhoea—Doxorubicin—thyroid cancer	0.000181	0.00181	CcSEcCtD
Erythromycin—Rash—Epirubicin—thyroid cancer	0.00018	0.00181	CcSEcCtD
Erythromycin—MLNR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—thyroid cancer	0.000179	0.00611	CbGpPWpGaD
Erythromycin—Dizziness—Doxorubicin—thyroid cancer	0.000175	0.00175	CcSEcCtD
Erythromycin—Nausea—Epirubicin—thyroid cancer	0.00017	0.0017	CcSEcCtD
Erythromycin—Vomiting—Doxorubicin—thyroid cancer	0.000168	0.00169	CcSEcCtD
Erythromycin—MLNR—Signaling by GPCR—CDK1—thyroid cancer	0.000167	0.00573	CbGpPWpGaD
Erythromycin—Rash—Doxorubicin—thyroid cancer	0.000167	0.00167	CcSEcCtD
Erythromycin—ABCC1—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000165	0.00565	CbGpPWpGaD
Erythromycin—CYP1A2—Metapathway biotransformation—CHST14—thyroid cancer	0.000159	0.00545	CbGpPWpGaD
Erythromycin—ABCB1—HIF-1-alpha transcription factor network—EPO—thyroid cancer	0.000158	0.00541	CbGpPWpGaD
Erythromycin—SLC22A7—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000158	0.00539	CbGpPWpGaD
Erythromycin—Nausea—Doxorubicin—thyroid cancer	0.000157	0.00157	CcSEcCtD
Erythromycin—SLCO1A2—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.000157	0.00538	CbGpPWpGaD
Erythromycin—SLCO1A2—SLC-mediated transmembrane transport—CP—thyroid cancer	0.000157	0.00538	CbGpPWpGaD
Erythromycin—MLNR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	0.000152	0.0052	CbGpPWpGaD
Erythromycin—CYP2B6—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.00015	0.00514	CbGpPWpGaD
Erythromycin—CYP3A5—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000147	0.00503	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000146	0.005	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—TSHR—thyroid cancer	0.000146	0.005	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—PRKAR1A—thyroid cancer	0.000144	0.00491	CbGpPWpGaD
Erythromycin—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000139	0.00477	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—MEN1—thyroid cancer	0.000137	0.0047	CbGpPWpGaD
Erythromycin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000136	0.00465	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000132	0.0045	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—PTCH1—thyroid cancer	0.000124	0.00425	CbGpPWpGaD
Erythromycin—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	0.000123	0.0042	CbGpPWpGaD
Erythromycin—SLCO1A2—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000118	0.00402	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—SST—thyroid cancer	0.000114	0.00388	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CALCA—thyroid cancer	0.000109	0.00374	CbGpPWpGaD
Erythromycin—CYP1A2—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000109	0.00373	CbGpPWpGaD
Erythromycin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000109	0.00371	CbGpPWpGaD
Erythromycin—CYP3A7—Biological oxidations—RXRA—thyroid cancer	0.000108	0.00369	CbGpPWpGaD
Erythromycin—SLC22A7—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000107	0.00366	CbGpPWpGaD
Erythromycin—SLC22A7—Transmembrane transport of small molecules—CP—thyroid cancer	0.000107	0.00366	CbGpPWpGaD
Erythromycin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—thyroid cancer	0.000106	0.00363	CbGpPWpGaD
Erythromycin—SLC22A7—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000105	0.0036	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—MINPP1—thyroid cancer	0.000101	0.00346	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CDK1—thyroid cancer	9.89e-05	0.00338	CbGpPWpGaD
Erythromycin—ABCB1—HIF-1-alpha transcription factor network—TERT—thyroid cancer	9.84e-05	0.00337	CbGpPWpGaD
Erythromycin—ABCB1—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	9.41e-05	0.00322	CbGpPWpGaD
Erythromycin—ABCC1—Disease—TRIM24—thyroid cancer	9.23e-05	0.00316	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—MINPP1—thyroid cancer	9.09e-05	0.00311	CbGpPWpGaD
Erythromycin—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	8.85e-05	0.00303	CbGpPWpGaD
Erythromycin—ABCC1—Disease—CHST14—thyroid cancer	8.68e-05	0.00297	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—NDUFA13—thyroid cancer	8.59e-05	0.00294	CbGpPWpGaD
Erythromycin—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	8.42e-05	0.00288	CbGpPWpGaD
Erythromycin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	8.38e-05	0.00287	CbGpPWpGaD
Erythromycin—ABCC1—Disease—TRIM33—thyroid cancer	8.23e-05	0.00282	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—CHST14—thyroid cancer	8.08e-05	0.00276	CbGpPWpGaD
Erythromycin—SLC22A7—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	8.01e-05	0.00274	CbGpPWpGaD
Erythromycin—SLCO1A2—Transmembrane transport of small molecules—CP—thyroid cancer	7.98e-05	0.00273	CbGpPWpGaD
Erythromycin—SLCO1A2—Transmembrane transport of small molecules—TPR—thyroid cancer	7.98e-05	0.00273	CbGpPWpGaD
Erythromycin—CYP2B6—Biological oxidations—RXRA—thyroid cancer	7.98e-05	0.00273	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—NRG1—thyroid cancer	7.94e-05	0.00272	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—MINPP1—thyroid cancer	7.93e-05	0.00271	CbGpPWpGaD
Erythromycin—SLCO1A2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	7.85e-05	0.00269	CbGpPWpGaD
Erythromycin—CYP3A5—Biological oxidations—RXRA—thyroid cancer	7.8e-05	0.00267	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—NDUFA13—thyroid cancer	7.73e-05	0.00265	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—CHST14—thyroid cancer	7.27e-05	0.00249	CbGpPWpGaD
Erythromycin—ABCC1—Transmembrane transport of small molecules—CP—thyroid cancer	7.18e-05	0.00246	CbGpPWpGaD
Erythromycin—ABCC1—Transmembrane transport of small molecules—TPR—thyroid cancer	7.18e-05	0.00246	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—TERT—thyroid cancer	7.13e-05	0.00244	CbGpPWpGaD
Erythromycin—ABCC1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	7.07e-05	0.00242	CbGpPWpGaD
Erythromycin—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	6.83e-05	0.00234	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—HIF1A—thyroid cancer	6.82e-05	0.00233	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—NDUFA13—thyroid cancer	6.74e-05	0.00231	CbGpPWpGaD
Erythromycin—SLC22A7—Transmembrane transport of small molecules—RXRA—thyroid cancer	6.73e-05	0.0023	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	6.71e-05	0.00229	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—HPGD—thyroid cancer	6.51e-05	0.00223	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—CHST14—thyroid cancer	6.34e-05	0.00217	CbGpPWpGaD
Erythromycin—CYP1A2—Arachidonic acid metabolism—PTGS2—thyroid cancer	6.27e-05	0.00215	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—NRAS—thyroid cancer	6.01e-05	0.00206	CbGpPWpGaD
Erythromycin—SLCO1A2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	5.98e-05	0.00204	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—MINPP1—thyroid cancer	5.86e-05	0.00201	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—HPGD—thyroid cancer	5.86e-05	0.002	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—MINPP1—thyroid cancer	5.73e-05	0.00196	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—BRAF—thyroid cancer	5.65e-05	0.00193	CbGpPWpGaD
Erythromycin—ABCC1—Disease—TCF7L1—thyroid cancer	5.49e-05	0.00188	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	5.41e-05	0.00185	CbGpPWpGaD
Erythromycin—ABCC1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	5.38e-05	0.00184	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	5.28e-05	0.00181	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	5.22e-05	0.00179	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—KRAS—thyroid cancer	5.17e-05	0.00177	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—HPGD—thyroid cancer	5.11e-05	0.00175	CbGpPWpGaD
Erythromycin—SLCO1A2—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.02e-05	0.00172	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	5e-05	0.00171	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—NDUFA13—thyroid cancer	4.99e-05	0.00171	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—NDUFA13—thyroid cancer	4.87e-05	0.00167	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4.75e-05	0.00163	CbGpPWpGaD
Erythromycin—CYP1A2—Biological oxidations—RXRA—thyroid cancer	4.7e-05	0.00161	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—CHST14—thyroid cancer	4.69e-05	0.0016	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—CHST14—thyroid cancer	4.58e-05	0.00157	CbGpPWpGaD
Erythromycin—ABCC1—Transmembrane transport of small molecules—RXRA—thyroid cancer	4.52e-05	0.00155	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	4.49e-05	0.00154	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—HRAS—thyroid cancer	4.39e-05	0.0015	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—MINPP1—thyroid cancer	4.33e-05	0.00148	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—AKT1—thyroid cancer	4.27e-05	0.00146	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CCND1—thyroid cancer	4.12e-05	0.00141	CbGpPWpGaD
Erythromycin—ABCC1—Disease—TPR—thyroid cancer	4.02e-05	0.00137	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—PTEN—thyroid cancer	3.98e-05	0.00136	CbGpPWpGaD
Erythromycin—ABCC1—Disease—PRKAR1A—thyroid cancer	3.95e-05	0.00135	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—AKT1—thyroid cancer	3.88e-05	0.00133	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	3.82e-05	0.00131	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—HPGD—thyroid cancer	3.78e-05	0.00129	CbGpPWpGaD
Erythromycin—ABCC1—Disease—MEN1—thyroid cancer	3.78e-05	0.00129	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—TPR—thyroid cancer	3.74e-05	0.00128	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—HPGD—thyroid cancer	3.69e-05	0.00126	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—PRKAR1A—thyroid cancer	3.68e-05	0.00126	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—NDUFA13—thyroid cancer	3.68e-05	0.00126	CbGpPWpGaD
Erythromycin—CYP3A4—Biological oxidations—RXRA—thyroid cancer	3.63e-05	0.00124	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—NRAS—thyroid cancer	3.55e-05	0.00121	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—CHST14—thyroid cancer	3.46e-05	0.00118	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—MINPP1—thyroid cancer	3.45e-05	0.00118	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	3.42e-05	0.00117	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	3.42e-05	0.00117	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—TPR—thyroid cancer	3.37e-05	0.00115	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	3.36e-05	0.00115	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.33e-05	0.00114	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—PRKAR1A—thyroid cancer	3.31e-05	0.00113	CbGpPWpGaD
Erythromycin—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	3.16e-05	0.00108	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—KRAS—thyroid cancer	3.05e-05	0.00105	CbGpPWpGaD
Erythromycin—ABCC1—Disease—CALCA—thyroid cancer	3.01e-05	0.00103	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3e-05	0.00103	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—NDUFA13—thyroid cancer	2.94e-05	0.001	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—TPR—thyroid cancer	2.93e-05	0.001	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—PRKAR1A—thyroid cancer	2.89e-05	0.000988	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—SLC5A5—thyroid cancer	2.8e-05	0.000958	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—HPGD—thyroid cancer	2.79e-05	0.000954	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—CHST14—thyroid cancer	2.76e-05	0.000945	CbGpPWpGaD
Erythromycin—ABCC1—Disease—CDK1—thyroid cancer	2.72e-05	0.000932	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—TP53—thyroid cancer	2.71e-05	0.000929	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	2.69e-05	0.00092	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—MINPP1—thyroid cancer	2.66e-05	0.000912	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.62e-05	0.000898	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—HRAS—thyroid cancer	2.6e-05	0.000888	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	2.56e-05	0.000875	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—SLC5A5—thyroid cancer	2.52e-05	0.000862	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	2.43e-05	0.000831	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.36e-05	0.000808	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—RXRA—thyroid cancer	2.35e-05	0.000805	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	2.35e-05	0.000802	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—AKT1—thyroid cancer	2.29e-05	0.000784	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.29e-05	0.000783	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—NDUFA13—thyroid cancer	2.27e-05	0.000775	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—HPGD—thyroid cancer	2.23e-05	0.000761	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—SLC5A5—thyroid cancer	2.2e-05	0.000752	CbGpPWpGaD
Erythromycin—ABCC1—Disease—NRG1—thyroid cancer	2.19e-05	0.000748	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—TPR—thyroid cancer	2.17e-05	0.000743	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.15e-05	0.000736	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—PRKAR1A—thyroid cancer	2.14e-05	0.000731	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—CHST14—thyroid cancer	2.13e-05	0.000729	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—TPR—thyroid cancer	2.12e-05	0.000726	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—RXRA—thyroid cancer	2.12e-05	0.000724	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	2.09e-05	0.000714	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.06e-05	0.000704	CbGpPWpGaD
Erythromycin—ABCC1—Disease—TERT—thyroid cancer	1.96e-05	0.000671	CbGpPWpGaD
Erythromycin—ABCC1—Disease—HIF1A—thyroid cancer	1.88e-05	0.000642	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—RXRA—thyroid cancer	1.85e-05	0.000632	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.8e-05	0.000618	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	1.8e-05	0.000616	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—HPGD—thyroid cancer	1.72e-05	0.000588	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—SLC5A5—thyroid cancer	1.62e-05	0.000556	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—TPR—thyroid cancer	1.6e-05	0.000548	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	1.6e-05	0.000548	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—SLC5A5—thyroid cancer	1.59e-05	0.000543	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—PRKAR1A—thyroid cancer	1.57e-05	0.000539	CbGpPWpGaD
Erythromycin—ABCC1—Disease—BRAF—thyroid cancer	1.55e-05	0.000532	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—PPARG—thyroid cancer	1.49e-05	0.000508	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—RXRA—thyroid cancer	1.37e-05	0.000467	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	1.35e-05	0.000462	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—PPARG—thyroid cancer	1.34e-05	0.000457	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—RXRA—thyroid cancer	1.33e-05	0.000457	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—TPR—thyroid cancer	1.28e-05	0.000437	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	1.26e-05	0.00043	CbGpPWpGaD
Erythromycin—ABCC1—Disease—PTGS2—thyroid cancer	1.26e-05	0.000429	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—SLC5A5—thyroid cancer	1.2e-05	0.00041	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—PTGS2—thyroid cancer	1.17e-05	0.0004	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—PPARG—thyroid cancer	1.17e-05	0.000399	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.14e-05	0.00039	CbGpPWpGaD
Erythromycin—ABCC1—Disease—PTEN—thyroid cancer	1.09e-05	0.000375	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—PTGS2—thyroid cancer	1.05e-05	0.00036	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—PTEN—thyroid cancer	1.02e-05	0.000349	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—RXRA—thyroid cancer	1.01e-05	0.000345	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—TPR—thyroid cancer	9.86e-06	0.000337	CbGpPWpGaD
Erythromycin—ABCC1—Disease—NRAS—thyroid cancer	9.77e-06	0.000334	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	9.7e-06	0.000332	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—SLC5A5—thyroid cancer	9.57e-06	0.000327	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—PTGS2—thyroid cancer	9.17e-06	0.000314	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—PTEN—thyroid cancer	9.17e-06	0.000314	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	8.96e-06	0.000307	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—PPARG—thyroid cancer	8.62e-06	0.000295	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—PPARG—thyroid cancer	8.42e-06	0.000288	CbGpPWpGaD
Erythromycin—ABCC1—Disease—KRAS—thyroid cancer	8.41e-06	0.000288	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—RXRA—thyroid cancer	8.04e-06	0.000275	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—PTEN—thyroid cancer	8e-06	0.000274	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	7.82e-06	0.000267	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—SLC5A5—thyroid cancer	7.38e-06	0.000253	CbGpPWpGaD
Erythromycin—ABCC1—Disease—HRAS—thyroid cancer	7.14e-06	0.000244	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—PTGS2—thyroid cancer	6.78e-06	0.000232	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—PTGS2—thyroid cancer	6.63e-06	0.000227	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—PPARG—thyroid cancer	6.36e-06	0.000218	CbGpPWpGaD
Erythromycin—ABCC1—Disease—AKT1—thyroid cancer	6.31e-06	0.000216	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—RXRA—thyroid cancer	6.2e-06	0.000212	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—PTEN—thyroid cancer	5.91e-06	0.000202	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—AKT1—thyroid cancer	5.87e-06	0.000201	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—PTEN—thyroid cancer	5.78e-06	0.000198	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—AKT1—thyroid cancer	5.28e-06	0.000181	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—PPARG—thyroid cancer	5.08e-06	0.000174	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—PTGS2—thyroid cancer	5e-06	0.000171	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—AKT1—thyroid cancer	4.61e-06	0.000158	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—PTEN—thyroid cancer	4.36e-06	0.000149	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—PTGS2—thyroid cancer	3.99e-06	0.000137	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—PPARG—thyroid cancer	3.92e-06	0.000134	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—PTEN—thyroid cancer	3.48e-06	0.000119	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—AKT1—thyroid cancer	3.41e-06	0.000117	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—AKT1—thyroid cancer	3.33e-06	0.000114	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—PTGS2—thyroid cancer	3.08e-06	0.000105	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—PTEN—thyroid cancer	2.69e-06	9.19e-05	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—AKT1—thyroid cancer	2.51e-06	8.6e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—AKT1—thyroid cancer	2.01e-06	6.87e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—AKT1—thyroid cancer	1.55e-06	5.3e-05	CbGpPWpGaD
